Published on 17 Apr 2023 on Simply Wall St. via Yahoo Finance
AtriCure, Inc.'s (NASDAQ:ATRC) Popularity With Investors Is Clear
AtriCure, Inc.'s (NASDAQ:ATRC) price-to-sales (or "P/S") ratio of 6.1x might make it look like a strong sell right now compared to the Medical Equipment industry in the United States, where around half of the companies have P/S ratios below 3.5x and even P/S below 1.5x are quite common. Although, it's not wise to just take the P/S at face value as there may be an explanation why it's so lofty.
View our latest analysis for AtriCure
